Actinium Pharmaceuticals Inc’s stock market performance has been somewhat irregular.
52-week price history of ATNM Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Actinium Pharmaceuticals Inc’s current trading price is -79.51% away from its 52-week high, while its distance from the 52-week low is 71.98%. The stock’s price range for this period has remained between $1.03 and $8.64. The Healthcare sector company’s shares managed to surpass a trading volume of around 0.52 million for the day, which was noticeably lower compared to the shares’ average daily volume of 0.65 million over the last three months.
Financial Performance and Market Capitalization
Actinium Pharmaceuticals Inc (ATNM) has experienced a quarterly rise of 53.91% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 55.22M and boasts a workforce of 37 employees.
Moving average and trading volume data
ATNM Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for ATNM stands at 0.06. Similarly, the long-term debt-to-equity ratio is also 0.03.
ATNM Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. Year to date metric has recorded a gain of 40.48%.However, over the last six months, we can see a weaker performance of 45.08%. Over the last 30 days, the price of ATNM has fallen by 19.59%. And in the last five days, it has surged by 5.36%.
